APA (7th ed.) Citation

Maggiolo, F., Gulminetti, R., Pagnucco, L., Digaetano, M., Benatti, S., Valenti, D., . . . Mussini, C. (2017). Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients. BMC infectious diseases, 17(1), 215. https://doi.org/10.1186/s12879-017-2311-2

Chicago Style (17th ed.) Citation

Maggiolo, Franco, Roberto Gulminetti, Layla Pagnucco, Margherita Digaetano, Simone Benatti, Daniela Valenti, Annapaola Callegaro, Diego Ripamonti, and Cristina Mussini. "Lamivudine/dolutegravir Dual Therapy in HIV-infected, Virologically Suppressed Patients." BMC Infectious Diseases 17, no. 1 (2017): 215. https://doi.org/10.1186/s12879-017-2311-2.

MLA (9th ed.) Citation

Maggiolo, Franco, et al. "Lamivudine/dolutegravir Dual Therapy in HIV-infected, Virologically Suppressed Patients." BMC Infectious Diseases, vol. 17, no. 1, 2017, p. 215, https://doi.org/10.1186/s12879-017-2311-2.